Supplemental Tables S1-S3 from The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in <i>MET</i>-Amplified Cancer

Abstract

&lt;p&gt;Supplemental Tables S1-S3. Table S1 describes the antiproliferative activity of SAR125844 on a panel of cell lines and the known genetic alterations of MET and other oncogenes or tumor suppressor genes for these cell lines. Table S2 describes the antiproliferative activity of SAR125844 upon various times of exposure in Hs 746T MET-amplified tumor cell line. Table S3 describes tumor exposure over plasma exposure ratios for SAR125844, JNJ-38877605 and PF-04217903 MET inhibitors.&lt;/p&gt;